Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-arwd-4_05-cv-04060/USCOURTS-arwd-4_05-cv-04060-1/pdf.json

Nature of Suit Code: 365
Nature of Suit: Personal Injury - Product Liability
Cause of Action: 28:1332 Diversity-Product Liability

---

AO72A

(Rev. 8/82)

 IN THE UNITED STATES DISTRICT COURT

WESTERN DISTRICT OF ARKANSAS

TEXARKANA DIVISION

LARRY DALE BELLEW PLAINTIFF

V. Civil No. 05-4060

GLAXO SMITHKLINE CORP., et al. DEFENDANTS

O R D E R

Now on this 23rd day of February 2006, there comes on for

consideration the report and recommendation issued by the Honorable

Bobby E. Shepherd, United States Magistrate Judge for the Western

District of Arkansas. (Doc. 14). Plaintiff filed written

objections to the report and recommendation. (Doc. 17).

The court has reviewed this case de novo and, being well and

sufficiently advised, finds as follows: The report and

recommendation is proper and should be and hereby is adopted in its

entirety. Accordingly, Separate Defendant Watson Pharmaceutical’s

motion to dismiss filed prior to removal is GRANTED; Separate

Defendants SmithKline Beecham Corporation d/b/a GlaxoSmithKline and

GlaxoSmithKline, PLC’s motions to dismiss (Docs. 2 & 7) are

GRANTED; and Separate Defendant Bret F. Craytor, M.D.’s motion to

dismiss (Doc. 8) is GRANTED. Accordingly, Plaintiff’s complaint is

DISMISSED WITH PREJUDICE.

IT IS SO ORDERED.

/s/ Robert T. Dawson

Honorable Robert T. Dawson

United States District Judge

Case 4:05-cv-04060-RTD Document 18 Filed 02/23/06 Page 1 of 1 PageID #: <pageID>